BACITRACIN ZINC AND POLYMYXIN B SULFATE OPHTHALMIC OINTMENT, USP
Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment, USP, is a sterile antimicrobial ointment for ophthalmic use. Each gram contains: bacitracin zinc equivalent to 500 bacitracin units, polymyxin B sulfate equivalent to 10,000 polymyxin B units, mineral oil, and white petrolatum.
Bacitracin zinc is the zinc salt of bacitracin, a mixture of related cyclic polypeptides (mainly bacitracin A) produced by the growth of an organism of the licheniformis group of Bacillus subtilis var Tracy. It has a potency of not less than 40 bacitracin units per mg.
Bacitracin Zinc and Polymyxin B Sulfate Ophthalmic Ointment is indicated for the topical treatment of superficial infections of the external eye and its adnexa caused by susceptible bacteria. Such infections encompass conjunctivitis, keratitis and keratoconjunctivitis, blepharitis and blepharoconjunctivitis.
Published Studies Related to Bacitracin Zinc and Polymyxin B (Bacitracin / Polymyxin B Ophthalmic)
Detection of IgE antibodies to bacitracin using a commercially available streptavidin-linked solid phase in a patient with anaphylaxis to triple antibiotic ointment. [2007.06]
BACKGROUND: Bacitracin is a commonly used topical antibiotic that has on occasion been reported to cause anaphylaxis. Evidence of the role of bacitracin specific IgE in such reactions has been demonstrated by skin testing. Because of the potential for provoking a systemic reaction by skin testing, it would be advantageous to develop an in vitro test for bacitracin specific IgE. OBJECTIVE: To report our experience coupling bacitracin to a solid phase and using it to detect specific IgE to bacitracin by fluorescent enzyme immunoassay... CONCLUSIONS: We demonstrate the presence of IgE antibodies to bacitracin in a patient with anaphylaxis to triple antibiotic ointment using a recently described procedure for producing custom allergen solid phases for immunoassay.
Clinical Trials Related to Bacitracin Zinc and Polymyxin B (Bacitracin / Polymyxin B Ophthalmic)
Use of Topical Tranexamic Acid and Bacitracin in Dialysis Patients [Not yet recruiting]
This study will investigate how the use of Tranexamic acid and Bacitracin applied to the
bleeding site after the hemodialysis fistula needle is removed will affect skin wound
Clinical Evaluation of Bacitracin [Completed]
Using Santyl or Bacitracin on Second Degree Burns [Withdrawn]
Subjects who have minor, second degree burns may be enrolled in this study. Subjects will
receive either Santyl ointment or bacitracin ointment to apply to the burn until it heals.
Bandages will be used to keep the burn covered while it heals. Second degree burns
generally leave a scar. Once the burn heals, lotion and an appropriate bandage will be used
to try to minimize the appearance of a scar.
The study hypothesis is that burns treated with Santyl will have a better scar appearance
than burns treated with bacitracin.
Subjects enrolled in this study will make once a week visits to the University of Kansas
Medical Center outpatient burn clinic until the burn heals. The burn will be assessed for
healing at these visits. Once healed, visits to the clinic will be every 1-3 months for up
to 1 year. At these visits, the appearance of the scar will be evaluated
The Relationship of Hemoglobin A1c and Diabetic Wound Healing [Terminated]
The purpose of this study is to investigate the relationship of hemoglobin A1c in diabetic
wound healing. Additionally, a comparison of two wound dressings, AmeriGel® (Amerx Health
Care Corp., Clearwater, FL) and Bacitracin, with and without vitamin C supplementation, will
be done to evaluate impact on time to wound closure.
Effectiveness of Antibiotic Delivery Via Bio-absorbable Sponge [Completed]
This study will evaluate the efficacy of a nasopore sponge dressing soaked in Bacitracin VS
a sponge soaked in Saline / and the administration of oral antibiotics.
Page last updated: 2007-10-18